76 related articles for article (PubMed ID: 16287998)
1. Noninvasive visualization of adenovirus replication with a fluorescent reporter in the E3 region.
Ono HA; Le LP; Davydova JG; Gavrikova T; Yamamoto M
Cancer Res; 2005 Nov; 65(22):10154-8. PubMed ID: 16287998
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein.
Doronin K; Toth K; Kuppuswamy M; Ward P; Tollefson AE; Wold WS
J Virol; 2000 Jul; 74(13):6147-55. PubMed ID: 10846098
[TBL] [Abstract][Full Text] [Related]
3. Transduction and oncolytic profile of a potent replication-competent adenovirus 11p vector (RCAd11pGFP) in colon carcinoma cells.
Silver J; Mei YF
PLoS One; 2011 Mar; 6(3):e17532. PubMed ID: 21455297
[TBL] [Abstract][Full Text] [Related]
4. Expanding the adenovirus toolbox: reporter viruses for studying the dynamics of human adenovirus replication.
King CR; Dodge MJ; MacNeil KM; Tessier TM; Mymryk JS; Mehle A
J Virol; 2024 May; 98(5):e0020724. PubMed ID: 38639487
[TBL] [Abstract][Full Text] [Related]
5. Evolving Horizons: Adenovirus Vectors' Timeless Influence on Cancer, Gene Therapy and Vaccines.
Trivedi PD; Byrne BJ; Corti M
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140619
[TBL] [Abstract][Full Text] [Related]
6. Biology of ovine adenovirus infection of nonpermissive cells.
Kümin D; Hofmann C; Rudolph M; Both GW; Löser P
J Virol; 2002 Nov; 76(21):10882-93. PubMed ID: 12368331
[TBL] [Abstract][Full Text] [Related]
7. New adenovirus vectors for protein production and gene transfer.
Massie B; Mosser DD; Koutroumanis M; Vitté-Mony I; Lamoureux L; Couture F; Paquet L; Guilbault C; Dionne J; Chahla D; Jolicoeur P; Langelier Y
Cytotechnology; 1998 Nov; 28(1-3):53-64. PubMed ID: 19003407
[TBL] [Abstract][Full Text] [Related]
8. Cancer imaging and therapy utilizing a novel NIS-expressing adenovirus: The role of adenovirus death protein deletion.
Robertson MG; Eidenschink BB; Iguchi E; Zakharkin SO; LaRocca CJ; Tolosa EJ; Truty MJ; Jacobsen K; Fernandez-Zapico ME; Davydova J
Mol Ther Oncolytics; 2021 Mar; 20():659-668. PubMed ID: 33816784
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of pancreatic cancer.
LaRocca CJ; Han J; Gavrikova T; Armstrong L; Oliveira AR; Shanley R; Vickers SM; Yamamoto M; Davydova J
Surgery; 2015 May; 157(5):888-98. PubMed ID: 25731784
[TBL] [Abstract][Full Text] [Related]
10. Locally-delivered T-cell-derived cellular vehicles efficiently track and deliver adenovirus delta24-RGD to infiltrating glioma.
Balvers RK; Belcaid Z; van den Hengel SK; Kloezeman J; de Vrij J; Wakimoto H; Hoeben RC; Debets R; Leenstra S; Dirven C; Lamfers ML
Viruses; 2014 Aug; 6(8):3080-96. PubMed ID: 25118638
[TBL] [Abstract][Full Text] [Related]
11. A novel approach for detecting viable and tissue-specific circulating tumor cells through an adenovirus-based reporter vector.
Wu P; Sokoll LJ; Kudrolli TA; Chowdhury WH; Ma R; Liu MM; Rodriguez R; Lupold SE
Prostate; 2014 Sep; 74(13):1286-1296. PubMed ID: 25065656
[TBL] [Abstract][Full Text] [Related]
12. Conditionally replicative adenoviral vectors for imaging the effect of chemotherapy on pancreatic cancer cells.
Kimura J; Ono HA; Kosaka T; Nagashima Y; Hirai S; Ohno S; Aoki K; Julia D; Yamamoto M; Kunisaki C; Endo I
Cancer Sci; 2013 Aug; 104(8):1083-90. PubMed ID: 23679574
[TBL] [Abstract][Full Text] [Related]
13. Generation of a novel, cyclooxygenase-2-targeted, interferon-expressing, conditionally replicative adenovirus for pancreatic cancer therapy.
Armstrong L; Arrington A; Han J; Gavrikova T; Brown E; Yamamoto M; Vickers SM; Davydova J
Am J Surg; 2012 Nov; 204(5):741-50. PubMed ID: 22748294
[TBL] [Abstract][Full Text] [Related]
14. Characterization of infectivity-enhanced conditionally replicating adenovectors for prostate cancer radiovirotherapy.
Oneal MJ; Trujillo MA; Davydova J; McDonough S; Yamamoto M; Morris JC
Hum Gene Ther; 2012 Sep; 23(9):951-9. PubMed ID: 22694073
[TBL] [Abstract][Full Text] [Related]
15. Delivery of interferon alpha using a novel Cox2-controlled adenovirus for pancreatic cancer therapy.
Armstrong L; Davydova J; Brown E; Han J; Yamamoto M; Vickers SM
Surgery; 2012 Jul; 152(1):114-22. PubMed ID: 22503318
[TBL] [Abstract][Full Text] [Related]
16. Enhanced transduction of CAR-negative cells by protein IX-gene deleted adenovirus 5 vectors.
de Vrij J; van den Hengel SK; Uil TG; Koppers-Lalic D; Dautzenberg IJ; Stassen OM; Bárcena M; Yamamoto M; de Ridder CM; Kraaij R; Kwappenberg KM; Schilham MW; Hoeben RC
Virology; 2011 Feb; 410(1):192-200. PubMed ID: 21130482
[TBL] [Abstract][Full Text] [Related]
17. Arming a replicating adenovirus with osteoprotegerin reduces the tumor burden in a murine model of osteolytic bone metastases of breast cancer.
Cody JJ; Rivera AA; Lyons GR; Yang SW; Wang M; Sarver DB; Wang D; Selander KS; Kuo HC; Meleth S; Feng X; Siegal GP; Douglas JT
Cancer Gene Ther; 2010 Dec; 17(12):893-905. PubMed ID: 20798695
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of adenovirus capsid labeling versus transgene expression.
Li J; Fatima A; Komarova S; Ugai H; Uprety P; Roth JC; Wang M; Oster RA; Curiel DT; Matthews QL
Virol J; 2010 Jan; 7():21. PubMed ID: 20102632
[TBL] [Abstract][Full Text] [Related]
19. Current issues and future directions of oncolytic adenoviruses.
Yamamoto M; Curiel DT
Mol Ther; 2010 Feb; 18(2):243-50. PubMed ID: 19935777
[TBL] [Abstract][Full Text] [Related]
20. In vivo bioimaging tracks conditionally replicative adenoviral replication and provides an early indication of viral antitumor efficacy.
Davydova J; Gavrikova T; Brown EJ; Luo X; Curiel DT; Vickers SM; Yamamoto M
Cancer Sci; 2010 Feb; 101(2):474-81. PubMed ID: 19900190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
